Ftse Mib
34.289,74
1,03%
DAX
18.173,03
1,39%
S&P 500
5.109,85
1,22%
NASDAQ Composite
15.925,46
2,01%
Bitcoin
63.980,76
-0,78%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Assistenza
Home Investire Azioni Regno Unito LSE N4 Pharma Plc (N4P) N4 Pharma Plc (N4P) Notizie

N4 Pharma Plc

N4P
0,775
-0,05 (-6,06%)
Ultimo aggiornamento: 16:32:48
Dati in Delay di 15 minuti
Borsa: Londra
Tipo: Azione Ordinaria
Valuta: GBX

Ultime notizie

Data Ora Fonte Titolo
26/4/202408:00LSEG_NONN4 Pharma PLC N4 Pharma Webinar on SRI Collaboration
25/4/202412:56ALNCNewsN4 Pharma strikes partnership deal for intracellular..
25/4/202408:38LSEG_RNSN4 Pharma PLC Collaboration Agreement with SRI International..
23/4/202414:32ALNCNewsIN BRIEF: N4 Pharma loss widens but "great optimism" remains
23/4/202408:00LSEG_RNSN4 Pharma PLC Final Results
18/4/202413:14ALNCNewsN4 Pharma sees potential in Nuvec delivery method for cancer..
18/4/202408:00LSEG_RNSN4 Pharma PLC Oral Delivery Update
04/3/202416:13LSEG_RNSN4 Pharma PLC Holding(s) in Company
29/2/202408:00LSEG_RNSN4 Pharma PLC Holding(s) in Company
15/2/202413:06ALNCNewsIN BRIEF: N4 Pharma shares rise on "encouraging" Nuvec..
15/2/202408:00LSEG_RNSN4 Pharma PLC in-vitro siRNA update
19/1/202410:26ALNCNewsIN BRIEF: N4 Pharma gets India patent for medical delivery..
19/1/202408:00UKREGN4 Pharma PLC Patent Grant
18/1/202411:15UKREGN4 Pharma PLC Holding(s) in Company
16/1/202414:26ALNCNewsIN BRIEF: N4 Pharma touts contract to test glaucoma..
16/1/202408:00UKREGN4 Pharma PLC Nanogenics Update
08/1/202417:24UKREGN4 Pharma PLC Holding(s) in Company
08/1/202410:11ALNCNewsN4 Pharma hails increased efficacy of Nuvec when complexed..
08/1/202408:00UKREGN4 Pharma PLC AAV Viral Vector Update
18/12/202313:43ALNCNewsN4 Pharma rises on successful results from Nuvec..
18/12/202308:00UKREGN4 Pharma PLC Oral Delivery Update
07/12/202319:28ALNCNewsTRADING UPDATES: N4 Pharma hails "encouraging" siRNA..
07/12/202312:28UKREGN4 Pharma PLC Holding(s) in Company
07/12/202308:00UKREGN4 Pharma PLC Nuvec(R) R&D and Strategy Update
01/12/202315:29ALNCNewsTRADING UPDATES: N4 launches investor hub; Capricorn..
30/11/202310:00RNSNONN4 Pharma PLC N4 Pharma Launches New Interactive Investor..
31/10/202308:00UKREGN4 Pharma PLC Total Voting Rights
09/10/202308:00RNSNONN4 Pharma PLC Investor Presentation via Investor Meet..
03/10/202309:15UKREGN4 Pharma PLC Holding(s) in Company
02/10/202308:00RNSNONN4 Pharma PLC Investor Presentation
28/9/202311:20ALNCNewsN4 Pharma shares fall as places shares to fund Nanogenics..
28/9/202308:00UKREGN4 Pharma PLC Acquisition of Controlling Interest in..
12/9/202314:43ALNCNewsN4 Pharma interim loss narrows slightly as business outreach..
12/9/202308:00UKREGN4 Pharma PLC Interim Results
25/7/202311:12ALNCNewsN4 Pharma shares soar on further patent grant for Nuvec in..
25/7/202308:00UKREGN4 Pharma PLC Patent Grant and Board Change
27/6/202313:13ALNCNewsIN BRIEF: N4 Pharma expands Professor Yu partnership on..
27/6/202308:00RNSNONN4 Pharma PLC Grant Award for Professor Chengzhong Yu
Apertura: 0,825 Min: 0,775 Max: 0,825
Chiusura: 0,825

La tua Cronologia

LSE
N4P
N4 Pharma
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network